David W Andrews

Summary

Affiliation: Thomas Jefferson University
Country: USA

Publications

  1. pmc Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma
    A Gabriella Wernicke
    Department of Stich Radiation Oncology, Weill Cornell School of Medicine at Cornell University, 525 East 68th Street, New York, New York 10065, USA
    Radiat Oncol 5:46. 2010
  2. pmc Multiple courses of stereotactic re-irradiation in recurrent oligodendroglioma: a case report
    Shannon Fogh
    Department of Radiation Oncology, University of California San Francisco, 505 Parnassus Ave, Room L 08, Box 0226, San Francisco, CA 94143, USA
    J Med Case Reports 5:183. 2011
  3. ncbi request reprint Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
    David W Andrews
    Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Lancet 363:1665-72. 2004
  4. doi request reprint Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohorts
    David W Andrews
    Department of Neurologic Surgery, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Int J Radiat Oncol Biol Phys 74:419-26. 2009
  5. doi request reprint Current neurosurgical management of brain metastases
    David W Andrews
    Department of Neurosurgery, Thomson Jefferson University, Jefferson Medical College, Philadelphia, PA 19107, USA
    Semin Oncol 35:100-7. 2008
  6. ncbi request reprint A review of 3 current radiosurgery systems
    David W Andrews
    Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Surg Neurol 66:559-64. 2006
  7. pmc Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas
    Shannon E Fogh
    Department of Radiation Oncology, Neurological Surgery, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA corrected
    J Clin Oncol 28:3048-53. 2010
  8. pmc The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
    Mark E Linskey
    Department of Neurosurgery, University of California Irvine Medical Center, Orange, CA, USA
    J Neurooncol 96:45-68. 2010
  9. pmc The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline
    Mario Ammirati
    Department of Neurosurgery, Ohio State University Medical Center, Columbus, OH, USA
    J Neurooncol 96:85-96. 2010
  10. pmc The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
    Steven N Kalkanis
    Department of Neurosurgery, Henry Ford Health System, 2799 West Grand Blvd, K 11, Detroit, MI 48202, USA
    J Neurooncol 96:33-43. 2010

Collaborators

Detail Information

Publications39

  1. pmc Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma
    A Gabriella Wernicke
    Department of Stich Radiation Oncology, Weill Cornell School of Medicine at Cornell University, 525 East 68th Street, New York, New York 10065, USA
    Radiat Oncol 5:46. 2010
    ..This study explores whether meningioma expresses epidermal growth factor receptor (EGFR) and determines if there is a correlation between the WHO grade of this tumor and the degree of EGFR expression...
  2. pmc Multiple courses of stereotactic re-irradiation in recurrent oligodendroglioma: a case report
    Shannon Fogh
    Department of Radiation Oncology, University of California San Francisco, 505 Parnassus Ave, Room L 08, Box 0226, San Francisco, CA 94143, USA
    J Med Case Reports 5:183. 2011
    ..abstract:..
  3. ncbi request reprint Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
    David W Andrews
    Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Lancet 363:1665-72. 2004
    ..We aimed to assess whether stereotactic radiosurgery provided any therapeutic benefit in a randomised multi-institutional trial directed by the Radiation Therapy Oncology Group (RTOG)...
  4. doi request reprint Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohorts
    David W Andrews
    Department of Neurologic Surgery, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Int J Radiat Oncol Biol Phys 74:419-26. 2009
    ..To describe our initial experience of fractionated stereotactic radiotherapy dose reduction comparing two dose cohorts with examination of tumor control rates and serviceable hearing preservation rates...
  5. doi request reprint Current neurosurgical management of brain metastases
    David W Andrews
    Department of Neurosurgery, Thomson Jefferson University, Jefferson Medical College, Philadelphia, PA 19107, USA
    Semin Oncol 35:100-7. 2008
    ..This chapter is devoted to a review of the current management options for treatment of brain metastases...
  6. ncbi request reprint A review of 3 current radiosurgery systems
    David W Andrews
    Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Surg Neurol 66:559-64. 2006
    ..Rapid evolution of new technologies has now enabled clinicians to treat tumors outside the cranium and down the spinal axis. This review compares 3 commercially available systems in widespread use throughout the world...
  7. pmc Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas
    Shannon E Fogh
    Department of Radiation Oncology, Neurological Surgery, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA corrected
    J Clin Oncol 28:3048-53. 2010
    ..We sought to determine the efficacy and toxicity profile of H-SRT alone or in addition to repeat craniotomy or concomitant chemotherapy...
  8. pmc The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
    Mark E Linskey
    Department of Neurosurgery, University of California Irvine Medical Center, Orange, CA, USA
    J Neurooncol 96:45-68. 2010
    ....
  9. pmc The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline
    Mario Ammirati
    Department of Neurosurgery, Ohio State University Medical Center, Columbus, OH, USA
    J Neurooncol 96:85-96. 2010
    ..What evidence is available regarding the use of whole brain radiation therapy (WBRT), stereotactic radiosurgery (SRS), surgical resection or chemotherapy for the treatment of recurrent/progressive brain metastases?..
  10. pmc The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
    Steven N Kalkanis
    Department of Neurosurgery, Henry Ford Health System, 2799 West Grand Blvd, K 11, Detroit, MI 48202, USA
    J Neurooncol 96:33-43. 2010
    ..There is insufficient evidence to make a recommendation for patients with poor performance scores, advanced systemic disease, or multiple brain metastases...
  11. pmc Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study
    Xinglei Shen
    Department of Radiation Oncology, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA
    Radiat Oncol 7:225. 2012
    ..We review the experience at Thomas Jefferson University using FSRT in the management of these patients with a focus on symptom outcomes...
  12. pmc The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
    Timothy C Ryken
    Department of Neurosurgery, Iowa Spine and Brain Institute, Iowa City, IA, USA
    J Neurooncol 96:103-14. 2010
    ..2) comparison of different doses of steroid therapy...
  13. pmc A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas
    Robert B Den
    Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Int J Radiat Oncol Biol Phys 85:321-8. 2013
    ..We sought to determine the safety and maximum tolerated dose of sorafenib when combined with both radiation and temozolomide in the primary setting or radiation alone in the recurrent setting...
  14. pmc Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas
    Colin E Champ
    Department of Radiation Oncology, Kimmel Cancer Center and Jefferson Medical College of Thomas Jefferson University, 111 S, 11th Street, Philadelphia, PA 19107, USA
    Radiat Oncol 7:220. 2012
    ..The deformation of the tumor bed and brain from surgery to RT is poorly studied. This study examined the magnitude of volume change in the postoperative tumor bed and the potential impact of RT planning...
  15. pmc A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies
    Evan J Wuthrick
    Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Kimmel Cancer Center, Philadelphia, Pennsylvania 19107, USA
    Cancer 117:5548-59. 2011
    ..In this phase 1 trial, the authors evaluated sunitinib combined with radiation therapy (RT) for the treatment of primary or metastatic central nervous system (CNS) malignancies...
  16. doi request reprint Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation
    Colin E Champ
    Department of Radiation Oncology, Kimmel Cancer Center and Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Neurosurgery 73:489-96. 2013
    ..Initial reports from our institution demonstrated that the reduction of treatment dose to 46.8 Gy resulted in improved preservation of functional hearing status...
  17. doi request reprint Improving prognosis of glioblastoma in the 21st century: who has benefited most?
    Yaacov Richard Lawrence
    Department of Radiation Oncology, Sheba Medical Center affiliated with Sackler School of Medicine, Tel Aviv University, Ramat Gan, Israel
    Cancer 118:4228-34. 2012
    ..Therefore, this study performed a population-based survival analysis of patients with newly diagnosed GBM covering the period before and after the introduction of temozolomide...
  18. doi request reprint Stereotactic radiotherapy for trigeminal schwannomas
    Colin E Champ
    Department of Radiation Oncology, Kimmel Cancer Center and Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Neurosurgery 71:270-7; discussion 277. 2012
    ..Data on radiotherapy for trigeminal schwannomas (TSs) and comparison of stereotactic radiosurgery (SRS) with fractionated stereotactic radiotherapy (FSRT) are limited...
  19. doi request reprint Revisiting anaplastic astrocytomas I: an expansive growth pattern is associated with a better prognosis
    Hugh D Moulding
    Department of Neurological Surgery, Thomas Jefferson University, 909 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
    J Magn Reson Imaging 28:1311-21. 2008
    ..To study whether anaplastic astrocytomas that are nonenhancing and/or well-circumscribed (expansive) are associated with a better prognosis...
  20. doi request reprint Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of nonacoustic cranial nerve schwannomas
    Timothy N Showalter
    Department of Radiation Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Neurosurgery 63:734-40; discussion 740. 2008
    ..To review outcomes after fractionated stereotactic radiotherapy (FSR) and stereotactic radiosurgery (SRS) for nonacoustic cranial nerve schwannomas...
  21. doi request reprint Radiotherapy for brain metastases
    Robert B Den
    Department of Radiation Oncology, Thomas Jefferson University, 111 South 11th Street, Bodine Cancer Center, Philadelphia, PA 19107, USA
    Neurosurg Clin N Am 22:37-44, vi. 2011
    ..At present, there is randomized control evidence supporting multiple treatment strategies incorporating radiotherapy...
  22. ncbi request reprint Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial
    Wenyin Shi
    Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, 19107, USA
    J Neurooncol 118:313-9. 2014
    ..We found Vorinostat administered with concurrent WBRT to be well tolerated to a dose of 300 mg once daily. This is the recommended dose for phase II study. ..
  23. pmc Reirradiation of recurrent meningioma
    Andrzej P Wojcieszynski
    Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    J Clin Neurosci 19:1261-4. 2012
    ..MTP was not reached for patients with grade 1/unknown tumors. Reirradiation for recurrent meningioma yields modest tumor control rates but for patients with grade II or III tumors, outcomes are poor...
  24. doi request reprint Characterization and outcomes of optic nerve gliomas: a population-based analysis
    Mark V Mishra
    Department of Radiation Oncology, Jefferson Medical College, Philadelphia, PA, USA
    J Neurooncol 107:591-7. 2012
    ..In conclusion, ONG are rare tumors seen predominantly in children. The overall prognosis of high-grade tumors remains poor in all age groups despite multi-modality treatment...
  25. doi request reprint Combined role of whole-brain radiation therapy and radiosurgery for the treatment of brain metastasis
    Robert B Den
    Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Prog Neurol Surg 25:228-35. 2012
    ..Unfortunately, there is no current role to the addition of chemotherapy to radiation therapy for brain metastases...
  26. pmc The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics
    Jeffrey J Olson
    Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA
    J Neurooncol 96:115-42. 2010
    ..What evidence is available regarding the emerging and investigational therapies for the treatment of metastatic brain tumors?..
  27. doi request reprint Revisiting anaplastic astrocytomas II: further characterization of an expansive growth pattern with visually enhanced diffusion tensor imaging
    Xin Guan
    Department of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    J Magn Reson Imaging 28:1322-36. 2008
    ..To seek to distinguish and visualize the different magnetic resonance imaging (MRI) growth patterns among malignant gliomas utilizing visually enhanced diffusion tensor imaging (DTI)...
  28. ncbi request reprint Multifocal glioblastoma multiforme: prognostic factors and patterns of progression
    Timothy N Showalter
    Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA
    Int J Radiat Oncol Biol Phys 69:820-4. 2007
    ....
  29. ncbi request reprint Impact of a standardized protocol and antibiotic-impregnated catheters on ventriculostomy infection rates in cerebrovascular patients
    James S Harrop
    Department of Neurosurgery, Jefferson Medical College, and Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA
    Neurosurgery 67:187-91; discussion 191. 2010
    ..A prospective observational study analyzed the effects of this protocol alone and with antibiotic-impregnated ventriculostomy catheters...
  30. doi request reprint Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers
    Michael Prosniak
    Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Clin Cancer Res 19:3776-86. 2013
    ..This study is directed at identifying the cell source(s) of immunomodulatory cytokines in high-grade gliomas and establishing whether the analysis of associated markers has implications for tumor grading...
  31. ncbi request reprint Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization
    Erol Veznedaroglu
    Department of Neurosurgery, Jefferson Hospital for Neuroscience, Philadelphia, Pennsylvania, USA
    Neurosurgery 55:519-30; discussion 530-1. 2004
    ..We review treatment of large AVMs either previously untreated or partially obliterated by embolization with fractionated stereotactic radiotherapy (FSR) regimens using a dedicated linear accelerator (LINAC)...
  32. doi request reprint Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas
    Peter G Campbell
    Department of Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Neurosurg Focus 29:E5. 2010
    ....
  33. ncbi request reprint Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells
    Jie Tang
    Department of Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Clin Cancer Res 11:5292-9. 2005
    ..A glioblastoma multiforme-specific T-cell assay was developed using monocyte-derived dendritic cells to present tumor antigens from the established glioblastoma multiforme cell line U118...
  34. ncbi request reprint Gliosarcoma arising from an anaplastic ependymoma: a case report of a rare entity
    Eric Behling
    Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA, USA
    Hum Pathol 35:512-6. 2004
    ..The spectrum of gliosarcoma is therefore expanded to include not only astrocytic and oligodendroglial components but ependymal components as well...
  35. ncbi request reprint Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques
    Sun Ha Paek
    Department of Neurosurgery, Seoul National University, Seoul, South Korea
    Neurosurgery 56:1021-34; discussion 1021-34. 2005
    ..Patients with brain metastases were analyzed retrospectively to assess the risks and benefits of surgery with modern neurosurgical techniques, including image guidance coupled as indicated with corticography...
  36. ncbi request reprint Glycerol rhizotomy versus gamma knife radiosurgery for the treatment of trigeminal neuralgia: an analysis of patients treated at one institution
    Clarissa Febles Henson
    Department of Radiation Oncology, Cooper University Medical Center, Camden, NJ, USA
    Int J Radiat Oncol Biol Phys 63:82-90. 2005
    ..Using a common pain scale outcomes questionnaire, we sought to analyze efficacies and morbidities of both treatments...
  37. ncbi request reprint Radiosurgery plus whole-brain radiation therapy for brain metastases
    Roy A Patchell
    JAMA 296:2089-90; author reply 2090-1. 2006
  38. ncbi request reprint Comments about the prospective randomized trial by Aoyama et al
    Roy A Patchell
    Surg Neurol 66:459-60. 2006
  39. ncbi request reprint Concomitant use of computer image guidance, linear or sigmoid incisions after minimal shave, and liquid wound dressing with 2-octyl cyanoacrylate for tumor craniotomy or craniectomy: analysis of 225 consecutive surgical cases with antecedent historical co
    Joon Cho
    Department of Neurosurgery, Konkuk University, Seoul, South Korea
    Neurosurgery 52:832-40; discussion 840-1. 2003
    ..Somerville, NJ) for tumor craniotomy or craniectomy in our attempt to optimize craniotomy or craniectomy for tumor...